2003
DOI: 10.1046/j.1365-2125.2003.01816.x
|View full text |Cite
|
Sign up to set email alerts
|

Antiepileptic drug hypersensitivity syndrome in a patient treated with valproate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2003
2003
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 5 publications
0
13
0
Order By: Relevance
“…Patients with viral reactivation of HHV-6 or EBV at day 0 (n = 14, patients 1, 2, 6, 10, 12, 13,17,19,21,22,23,30,31, and 38) more frequently had facial edema (100% versus 70%, P = 0.03), lymphadenopathies (100% versus 58%, P = 0.01), and monocytosis (1740 cells/mm 3 versus 730 cells/mm 3 , P = 0.01) than did patients without (table S1).…”
Section: Viral Reactivation and Antiviral Cd8 + T Cell Responsesmentioning
confidence: 99%
“…Patients with viral reactivation of HHV-6 or EBV at day 0 (n = 14, patients 1, 2, 6, 10, 12, 13,17,19,21,22,23,30,31, and 38) more frequently had facial edema (100% versus 70%, P = 0.03), lymphadenopathies (100% versus 58%, P = 0.01), and monocytosis (1740 cells/mm 3 versus 730 cells/mm 3 , P = 0.01) than did patients without (table S1).…”
Section: Viral Reactivation and Antiviral Cd8 + T Cell Responsesmentioning
confidence: 99%
“…Arevalo-Lorido et al (4) reported a case of DRESS following exposure to carbamazepine and recurring during treatment with valproate. They suggested that a reaction of circulating antibodies to anti-epileptic drugs was responsible for triggering a clinical cross-reactivity between carbamazepine and valproate.…”
Section: Discussionmentioning
confidence: 98%
“…Cross-sensitivity is as high as 75% among the aromatic anticonvulsants (15,16) and the cross-sensitivity between valproate and the aromatic anticonvulsants has also recently been reported (4,5).…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…Another case report described a patient who, after resolution of symptoms caused by carbamazepine-induced AHS, was given VPA and immediately developed life-threatening AHS. 14 In addition, Cogrel and colleagues 15 reported an AHS-like condition with VPA treatment. The patient recovered after the VPA was discontinued.…”
Section: Introductionmentioning
confidence: 99%